Jump to section
To revolutionise how patients acquire, use, and experience medicinal cannabis by offering an all-in-one monthly subscription that delivers safety, convenience, and choice.
In the UK's medical cannabis landscape, accessibility for patients seeking prescription-strength cannabis has been a persistent challenge. The existing process lacks efficiency, and navigating regulatory complexities poses hurdles for both patients and providers.
Releaf has emerged to address these challenges by offering a medical cannabis subscription service. Through online consultations, the company facilitates a streamlined process for patients to obtain prescription-strength cannabis.
Boasting a substantial early access waiting list and a growing team, along with several successful funding rounds, Releaf positions itself to become the largest cannabis company in the UK, with projections indicating significant growth within 24 months of the clinic's opening. As the company works towards certifications for its software, it ensures a robust foundation for sustained success and impact in the evolving medical cannabis landscape.
Kirsty
Company Specialist at Welcome to the Jungle
Mason Soiza
(CEO)Co-Founded the Meds Group in 2016 and has served as a Non-Executive Director ever since.
Oliver Soar
(CTO)Alongside serving as Releaf's CTO, they are the Technical Director at UK Meds. Previously worked as a Systems Developer at Yu Energy.